Cargando…
Therapie des Typ-2-Diabetes
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191539/ http://dx.doi.org/10.1007/s11428-022-00921-5 |
| _version_ | 1784726035660537856 |
|---|---|
| author | Landgraf, Rüdiger Aberle, Jens Birkenfeld, Andreas L. Gallwitz, Baptist Kellerer, Monika Klein, Harald H. Müller-Wieland, Dirk Nauck, Michael A. Wiesner, Tobias Siegel, Erhard |
| author_facet | Landgraf, Rüdiger Aberle, Jens Birkenfeld, Andreas L. Gallwitz, Baptist Kellerer, Monika Klein, Harald H. Müller-Wieland, Dirk Nauck, Michael A. Wiesner, Tobias Siegel, Erhard |
| author_sort | Landgraf, Rüdiger |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9191539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Medizin |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91915392022-06-17 Therapie des Typ-2-Diabetes Landgraf, Rüdiger Aberle, Jens Birkenfeld, Andreas L. Gallwitz, Baptist Kellerer, Monika Klein, Harald H. Müller-Wieland, Dirk Nauck, Michael A. Wiesner, Tobias Siegel, Erhard Diabetologie DDG Praxisempfehlungen Springer Medizin 2022-06-13 2022 /pmc/articles/PMC9191539/ http://dx.doi.org/10.1007/s11428-022-00921-5 Text en © The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | DDG Praxisempfehlungen Landgraf, Rüdiger Aberle, Jens Birkenfeld, Andreas L. Gallwitz, Baptist Kellerer, Monika Klein, Harald H. Müller-Wieland, Dirk Nauck, Michael A. Wiesner, Tobias Siegel, Erhard Therapie des Typ-2-Diabetes |
| title | Therapie des Typ-2-Diabetes |
| title_full | Therapie des Typ-2-Diabetes |
| title_fullStr | Therapie des Typ-2-Diabetes |
| title_full_unstemmed | Therapie des Typ-2-Diabetes |
| title_short | Therapie des Typ-2-Diabetes |
| title_sort | therapie des typ-2-diabetes |
| topic | DDG Praxisempfehlungen |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191539/ http://dx.doi.org/10.1007/s11428-022-00921-5 |
| work_keys_str_mv | AT landgrafrudiger therapiedestyp2diabetes AT aberlejens therapiedestyp2diabetes AT birkenfeldandreasl therapiedestyp2diabetes AT gallwitzbaptist therapiedestyp2diabetes AT kellerermonika therapiedestyp2diabetes AT kleinharaldh therapiedestyp2diabetes AT mullerwielanddirk therapiedestyp2diabetes AT nauckmichaela therapiedestyp2diabetes AT wiesnertobias therapiedestyp2diabetes AT siegelerhard therapiedestyp2diabetes |